HOME

R E F E R E N C E S

Bryan CP: Ancient Egyptian Medicine: The papyrus Ebers. London, Ares. 1930.

Jones WHS, Withington ET: Hippocrates, vol. 4, Cambridge, MA. Harvard University Press 1923-1931.

Mettler CC: History of Medicine. Philadelphia, Blakiston, 1947.

Sonnenburg E, Tschmarke P: Die Verbrennungen und Die Erfrierungen. Stuttgart, 1915, p 618.

Dzondi KH: Ueber Verbrennungen und das Einzige. Sichere Mittel sie in Jedem Grade Schnell and Schmerzlos zu Heilen. Halle, Hemmerde und Schwetschke, 1816, p 1-64.

Hebra FV. Ueber continierliche allgemeine bader und deren anwen-dung bei behandlung von verbrennungen. Allgemeine Wiener Medizinische Zeitung 1861:6;351-352, 359-360.

Erichsen JE. On the pathology of burns. London Medical Gazette 1843:31;524-533, 588-593.

Copeland WP. The treatment of burns. The Medical Record (NY) 1887:31;518.

Sneve H. The treatment of burns and skin grafting. JAMA 1905:45;1-8.

John DS. The open air treatment of burns. Am J Surg 1910:24;255-256.

Artz CP: Historical aspects of burn management. Surg Clin North Am Dec 1970:50;6, 1193-1200.

Davidson EC. Tannic acid in the treatment of burns. Surg Gyn Obstet 1925:41;202.

Aldrich RH. Treatment of burns with a compound of aniline dyes. N Engl J Med 1937:217;911-914.

Moncrief J: The development of topical therapy. J Trauma 1971:11;906-910.

Fox CL: Topical therapy and the development of silver sulfadiazine. Surg Gynecol Obstet 1983:157;82-88.

Winter G. Formation of the scab and rate of epithelialization of superficial wounds in the skin. Nature 1962:193;293.

Wheeland RG. Wound healing and the newer surgical dressings. In: Moschella St., Hurley HJ, et al, eds. Dermatology, Philadelphia: WB Saunders 1992:2305-11.

Silverman RA, Lender J, Elmets CA. Effects of occlusive and semiocclusive dressings in the return of barrier function to trans-epidermal water loss in standardized human wounds. J Am Acad Dermatology 1989:20;755-60.

Mertz PM, Eaglstein WH. The effect of a semiocclusive dressing on the microbial population in superficial wounds. Arch Surgery 1984:119:287-9.

Katz MH, Alvarez AF, Kirsner RS, et al. Human wound fluid from acute wounds stimulates fibroblast and endothelial cell growth. J Am Acad Dermatol 1991:25;1054-8.

Madden MR, Nolan E, Finkelstein JL, et al. Comparison of an occlusive and semi-occlusive dressing and the effect of the wound exudate upon Keratinocyte proliferation. J Trauma 1989:29;924-31.

Kannon G, Garrett A. Most wound healing with occlusive dressings. Dermatol Surg 1995:21;583.

Field C, Kerstein M. Overview of wound healing in a moist environment. Am J Surg 1994:167;2.

Bolton L, Monte K, Pirone L. Moisture and healing: beyond the jargon. Ostomy/Wound Management 2000:46;51.

Madden M, Nolan E, Finkelstein J. Comparison of an occlusive and semiocclusive dressing and the effect of the wound exudate upon keratinocyte proliferation. J Trauma 1989:29;924.

Vogt P, et al. Dry, moist and wet skin wound repair. Ann Plast Surg 1995:34;493.

Mertz P, Eaglstein W. The effect of a semiocclusive dressing on the microbial population in superficial wounds. Arch Surg 1984:119;287.

Brueing K, Eriksson E, et al. Healing of partial thickness wounds in a liquid environment. J Surg Res 1992:52;50.

Davies J. Synthetic materials for covering burn wounds: progress toward perfection. Part 1: Short term dressing material. Burns 1984:10;94.

Deitch E, Bacter C. Failure of local immunity: a potential cause of burn wound sepsis. Arch Surg 1985:120;78.

Hutchinson J, McGuckin M. Occlusive dressings: microbiologic and clinical reviews. Am J Infect Control 1990:18;257.

Breuing KH, Eriksson E, Liu PY, Miller DR. Healing of partial thickness procine skin wounds in a liquid environment. Journal of Surgical Research. 1992:52(1); 50-58.

Vogt PM, Breuing KH, Liu PY, Binder T, Eriksson E. Both wet and moist wound environments accelerate epithelialization. In: Altmeyer et al (eds); Wound healing and skin physiology. Springer 1993.

Vogt PM, Andree C, Breuing KH, Liu PY, Slama J, Helo G, Eriksson E. Dry, moist and wet skin wound repair. Ann Plast Surg 1995:34;493-500

Moncrief J. Topical therapy of the burn wound: present status. Clin Pharmacol Ther 1969:10;439.

Artz C. Historical aspects of burn management. Surg Clin N Amer 1970:50;6.

Moncrief J. The development of topical therapy. J Trauma 1971:11;998.

Boswick J. The role of dressings in treating burn wounds. In: The art and science of burn care 1987: Aspen Pub, pg 53.

Park G. Burn wound dressings – a review. Biomed Med Dev 1978:6;1.

Salisbury R, Wilmore D. Biological dressing for skin graft donor site. Arch Surg 1973:100;705.

Tavis M, et al. Modified collagen membrane as a skin substitute. J Biomed Mater Res 1975:9;785.

Deitch E. Failure of local immunity: a potential cause of burn wound sepsis. Arch Surg 1985:120;78.

Zawacki B. Reversal of capillary stasis and prevention of necrosis in burns. Ann Surg 1979:180;98.

Monafo W. Bessey P. Wound care; In Total burn care. Editor D Herndon, Saunders 1997:, pg 88.

Monafo W. Current treatment recommendations for topical burn therapy. Drugs 1990:40;364.

Fox C et al. Topical chemotherapy for burns using cerium salts and silver sulfadiazine. Surg Gynec Obstet 1977:144;668.

Hagger J et al. Antimicrobial therapy in burn patients. Surg Rounds 1992:699.

Robson M. Bacterial control in the burn wound. Clin Plas Surg 1979:6:515.

Moncreif J ET al. The use of a topical sulfonamide in the control of burn wound sepsis. J Trauma 1966:6;907.

Robson M. The use of topical agents to control bacteria in the burn wound. Dimick A editor 1977, pg 17.

Robson M. Burn sepsis. Crit Care Clinics 1988:4;281.

Lindberg R, et al. Control of experimental and clinical burn wound sepsis by topical application of sulfamylon compounds. Ann NY Acad Sci 1998:150;950.

Fox C. Silver sulfadiazine: a new topical therapy for pseudomonas in burns. Arch Surg 1968:96;184.

Boulton L. Topical agents and moist healing. Clin Dermat 1994:12;95.

Orgill D, Demling RH./ Current concepts and approaches to wound healing. Crit Care Med 1988:16;899-908.

Cooper ML, Boyce ST. Hansbrough JF, Foreman TJ, Frank DH. Cytotoxicity to cultured human keratinocytes of topical antimicrobial agents. J Surg Res 1990:48;190195.

Linweaver H. Topical antimicrobiol toxicity. Arch Surg 1985:120;267.

Boyce ST, Warden GD, Holder IA. Cytotoxicity testing of topical antimicrobial agents on human keratinocytes and fibroblasts for cultured skin grafts. J Burn Care Rehab 1995:16:97-103.

Smoot EC, Kucan JO, Roth A, Mody N, Debs N. In vitro toxicity testing for antibacterials against human keratinocytes. Plast Reconstr Surg 1991:87;917-924.

McCauley RL, Li YY, Poole B, Evans MJ, Robson MC, Heggers JP, Herndon DN. Differential inhibition of human basal keratinocyte growth to silver sulfadiaine and mafenide acetate. J Surg Res 1992:52;276-285.

Aldrich R. The role of infection in burns, therapy and treatment. New Eng J Med 1933:208;249.

Krizek T, Robson M, Bacterial growth and skin graft survival. Surg Forum 1967:18;516.

Bacchetta C, Magee W, Rodeheates G, et al. Biology of infections of split thickness skin grafts. Am J Surg 1975:130;63.

Neely A, Childress C, Maley M, Holder. Causes of colonization of autografted burn wounds. J Burn Care Rehab 1991:12;299.

Robson M, Stenberg B, Heggers J. Wound healing alterations caused by infection. Clin Plast Surg 1990:17;485.

Holdor I, Boyce S. Formulation of idealized topical antimicrobial mixture for use with cultured skin grafts. J Antimicrob Chemother 1996:38;457.

Livingston D, Cryer N, et al. A randomized prospective study of topical antibiotic agents on skin grafts after thermal injury. J Plast Reconstr Surg 1998:19;105.

Maggi S, Soler P, Robson M. The efficacy of 5% sulfamylon solution for the treatment of contaminated explanted human meshed skin grafts. Burns 1999:5;237.

Shuck JM, Einfeldt LE, Trainor MP. Sulfamylon solution dressings in the management of burn wounds: Preliminary clinical report. J Trauma 1972:12;999-1002.

Kucan JO, Smoot EC. Five percent mafenide acetate solution in the treatment of thermal injuries. J Burn Care Rehab 1993:144;158-163.

Harries RHC, Rogers BG, Leitch IOW, Robson MC. An in vivo model for epithelialization kinetics in human skin. Aust N.Z.J. Surg 1995:65;600-3.

Lee JJ, Marvin JA, Heimbach DM, Grube BJ. Use of 5% sulfamylon (mafenide) solution after excision and grafting of burns. J Burn Care Rehab 1988:9;602-5.

Mendelson J. Management of burns under condition of limited resources using topical aqueous sulfamylon spray. J Burn Care Rehab 1997:18;258.

Hanson N, Shuck G. Studies of the pain produced by mafenide acetate preparation in burns. Arch Surg 1975:110;1446.

Currerri P, Shuck J, Pruitt B. Treatment of burn wounds with 5% aqueous sulfamylon and occlusive dressings. Surg Forum 1970:20;506.

Lee J, Marvin J, Heimbach D. Use of 5% sulfamylon solution after excision and grafting in burns. J Burn Care Rehab 1988:9;602.

Harrison H, Bales N, Jacoby F. The absorption into burned skin of sulfamylon acetate from 5% aqueous solution. J Trauma 1972:12;794.

Murphy R, Kucan J, Robson M, Higgers J. The effect of 5% mafenide acetate solution on bacterial control in rat burns. J Trauma 1982:23;878.